Clinical Trials Directory

Trials / Completed

CompletedNCT02244996

Cone Rescue in Retinitis Pigmentosa by the Treatment of Lycium Barbarum

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
50 (actual)
Sponsor
The Hong Kong Polytechnic University · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

Objectives: To study the immediate effect and the persistent effect of Lycium barbarum (LB) treatment on retinal functions, especially the cone function, and retinal structure in patients with retinitis pigmentosa (RP) Design: Randomised controlled double-masked trial Setting: Primary Care clinical trial Participants: 120 RP subjects will be recruited from Ophthalmology department at The University of Hong Kong and the Retina Hong Kong. Interventions: Subjects will be randomly allocated to LB (treated with LB granules) or control (treated with placebo) groups for 1 year. After the 1st year, both groups will stop the treatment and all subjects will also have the same eye exam in 6-month period for the 2nd year. Main outcome measures: The primary outcome is the total sensitivity scores of 30-2 \& 60-4 programmes of Humphrey Visual Field Analysis (HVFA). The secondary outcomes are the b-wave amplitudes of Full-field Electroretinogram (ffERG) responses, the amplitudes of direct component and induced component of Multifocal Electroretinogram (mfERG), and the ETDRS visual acuity.

Detailed description

The study was a randomized controlled trial with a double-masked, placebo-controlled design. All the subjects were randomly allocated into either LB (treatment) group or placebo (control) group. All the eligible subjects had the eye examination, including VA using the Early Treatment of Diabetic Retinopathy Study (ETDRS) chart, refractions, tonometry, external and internal ocular health assessments, and fundus photo-documentation. Three additional tests were conducted to investigate the functional and structural changes in the RP patients, including Ganzfeld Electroretinogram, Humphrey Visual Field Analyser (Zeiss, Dublin, USA) and Spectral-domain Optical Coherent Tomography (SD-OCT) (Heidelberg Engineering, USA).

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTLycium BarbarumTraditional Chinese Herbs
DIETARY_SUPPLEMENTPlaceboPlacebo

Timeline

Start date
2014-11-01
Primary completion
2016-04-01
Completion
2017-11-01
First posted
2014-09-19
Last updated
2019-02-19
Results posted
2019-01-28

Locations

1 site across 1 country: Hong Kong

Source: ClinicalTrials.gov record NCT02244996. Inclusion in this directory is not an endorsement.